Samarium (153Sm) lexidronam Terminated Phase 2 Trials for Metastatic Bone Sarcomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01886105Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma